Lithium & Renal Damage: Prevention?

How to Minimize Renal Damage Risk with Chronic Lithium Use?

By Harvinder Singh, MD

Lithium is considered the gold standard treatment for bipolar disorder, but its use is limited due to the presence of a side effects profile. Physicians should be aware of these adverse events, their treatment, and monitoring guidelines.

The renal effects of lithium, including polyuria and polydipsia, are one of the common side effects seen in 70% of patients on long-term lithium treatment. 

Here is the summary of guidelines to prevent the risk of renal damage with chronic lithium use:

Note: This section is from one of the lectures in our upcoming conference: 

Psychiatry Education Forum’s Bipolar Disorder Update 2020:

PSYCHIATRY EDUCATION FORUM'S SECOND ONLINE CME CONFERENCE:

Lithium & Renal Damage: Prevention?

We guarantee that you will be accessing the most updated information for your invested time at a highly affordable cost.

RELEASE DATE: DEC 15, 2020

EARLY-BIRD ENROLLMENT OPEN 

Psychiatry Education Forum continues to provide high-quality, practice-oriented evidence to improve your clinical decision-making. We are enthralled to release our second online CME conference. Once again, we guarantee that you will be accessing the most updated information for your invested time at a highly affordable cost.

Our second conference focuses exclusively on one of the most important aspects of your practice:

Managing Various Aspects of Bipolar Disorder.

CONFERENCE INTRODUCTION VIDEO:

CME ACCREDITATIONS

8.75 AMA PRA Category 1 Credits Available

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute, LLC and the Psychiatry Education Forum LLC. PeerPoint Medical Education Institute, LLC is accredited by the ACCME to provide continuing medical education for physicians.

PeerPoint Medical Education Institute, LLC designates this live activity for a maximum of 8.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Related Articles